Clinical Trial: Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma
Brief Summary: The purpose of this study is to validate of a predictive nomogram of response or resistance to targeted therapies in metastatic clear cell renal cell carcinoma
Detailed Summary:
Sponsor: Rennes University Hospital
Current Primary Outcome: Primary refractory patients (Progression Free Survival (PFS) [ Time Frame: at 3 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Rennes University Hospital
Dates:
Date Received: July 26, 2016
Date Started: December 2014
Date Completion:
Last Updated: July 27, 2016
Last Verified: July 2016